CD33 and Alzheimer disease: For example, expression of immune receptors, such as triggering receptor expressed on myeloid cells 2 (TREM2) [85] and CD33 [86, 87], has been found to be associated with AD, suggesting that neuroinflammation contributes to the onset and progression of AD [84].